"cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular Carcinoma

NCT06590844 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

37

Enrollment

OTHER_GOV

Sponsor class

Conditions

Unresectable Hepatocellular Carcinoma

Interventions

DRUG: Injectable coenzyme I

Sponsor

Anhui Provincial Hospital